Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Taiwan Weighs National Health Plan Coverage Of Tamiflu

This article was originally published in PharmAsia News

Executive Summary

Taiwan is considering whether to cover doses of Roche's Tamiflu (oseltamivir) under its national health insurance program. The health ministry and Centers for Disease Control expect a preliminary decision to be made before July 24. A decision for healthcare coverage would free hospitals to buy directly from Roche, but a concern is an immediate increase in demand for the antiviral could cause a nationwide shortage. One plan is to give priority to people who test positive for the H1N1 flu virus under a quick-screening process, with clinical doctors having the final say on who should receive priority. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072255

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel